![Page 1: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/1.jpg)
Professor Andrew ShennanWomens Academic Health CentreKings College London,St Thomas’ Campus OAA
Torquay
2015
NIHR, BIG data and how to avoid statistical errors
![Page 2: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/2.jpg)
“Compare like with like…..”
![Page 3: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/3.jpg)
![Page 4: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/4.jpg)
![Page 5: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/5.jpg)
To improve the health and wealth of the nation through research
National Institute for Health ResearchStrategic Aim
www.nihr.ac.uk
• Established in 2006 as part of “Best Research for Best Health”;a Government Strategy
• Budget approximately 1% of NHS spend (£1billion)
• Goals:• Transform research in the NHS• Increase the volume of applied health research for the
benefit of patients and the public• Develop and support the people who conduct and
contribute to applied health research• Support industry and growth
![Page 6: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/6.jpg)
The NIHR Health Research System
Research
Research Projects & Programmes
Research Governance
Systems
Research Information
Systems
Patients&
Public
Universities
Investigators &Senior
InvestigatorsAssociatesTrainees
Research Schools
NHS TrustsClinical Research Networks
Clinical Research Facilities, Centres
& Units
Infrastructure
Systems
Faculty
![Page 7: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/7.jpg)
Clinical Specialties
Division 1
Cancer
Division 2
Cardiovascular
Diabetes
Metabolic & Endocrine
Renal
Stroke
Division 3
Children
Genetics
Haematology
Reproductive health & childbirth
Division 4
DENDRON
Mental health
Neurology
Division 5
Ageing
Dermatology
Health services research
Musculoskeletal
Oral & dental
Primary care
Public health
Division 6
Anaesthesia & pain
Critical care
Ear, nose & throat
Gastroenterology
Hepatology
ID & microbiology
Injuries & emergencies
Ophthalmology
Respiratory
Surgery
![Page 8: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/8.jpg)
Number of Open Studies by main topic (UK-wide)
0
100
200
300
400
500
600
![Page 9: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/9.jpg)
Anaesthesia:Plenty of Scope for doing more!
![Page 10: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/10.jpg)
RESPITEA Randomised Controlled Trial of Remifentanil intravenous Patient Controlled analgesia (PCA) versus intramuscular
pethidine for pain relief in labour
ISRCTN29654603 EUDRACT # 2012-005257-22
![Page 11: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/11.jpg)
Effect site concentration
Remifentanil
Alfentanil
Sufentanil
Pethidine
![Page 12: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/12.jpg)
Remifentanil vs. Pethidine Superior analgesia↑Maternal satisfaction Sedation similar
Fetal effects equivalentHeart Rate APGAR 5°AcidosisNeurobehavioral
![Page 13: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/13.jpg)
The Health and Social Care Act (2012)
• Places a clear duty on the Secretary of State, the NHS
Commissioning Board and Clinical Commissioning Groups to
promote research on matters relevant to the health service,
and the use in the health service of evidence obtained from
research
• NHS Constitution: clinical research is “core business” for the
NHS; patients have a right to participate in a clinical trial if
they are suitable for it
• Rapid adoption of effective innovations to characterise NHS
![Page 14: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/14.jpg)
NHS Constitution: article 3a includes a "pledge" to inform patients when they "may
be eligible" to participate in a research study
![Page 15: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/15.jpg)
Respite trial: PPI rep
"I wanted to take part. I read about it, tried to meet people who could help, and even put it in my birth plan. They just weren't interested. It was really upsetting."
![Page 16: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/16.jpg)
Hierarchy of evidence based medicine
Individual experienceCollective experience
Case reportCase series
Cohort: observationalCohort: case control
Randomised Controlled TrialsMeta-analysis of RCTs
![Page 17: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/17.jpg)
EvidenceWe don’t have to study everything
Parachute or snowboard, jumping out of a plane?
![Page 18: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/18.jpg)
Evidence• Doing the study dosn’t always mean we
find the right answer: generalisability
![Page 19: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/19.jpg)
Case reports• Hall M, Vousden N, Carter J, Hezelgrave N, Shennan AH.
Prevention of mid-trimester loss following full dilatation caesarean section: a potential role for transabdominal cervical cerclage. J Obstet Gynaecol. 2015 Jan;35(1):98-9. doi: 10.3109/01443615.2014.940302.
• Anderson-Knight HE, Hezelgrave NL, Shennan AH. Spontaneous resolution of a midtrimester dilated cervix with expectant management guided by quantitative fetal fibronectin results. J Obstet Gynaecol. 2015 Mar 16:1-2. [Epub ahead of print] No abstract available. PMID:25774648
• Calvert B, Hezelgrave N and Shennan AH. Successful vaginal delivery following an abdominal cerclage, predicted by serial vaginal cervical ultrasound. J Obstet Gynaecol 2015. In press.
![Page 20: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/20.jpg)
![Page 21: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/21.jpg)
Statistical errors….lies, damn lies and statistics
![Page 22: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/22.jpg)
Statistical Errors
• 0 Right answer wrong question• 1 A difference exists that isn't real• 2 No difference is found when one exists• 3 Significant answer, wrong direction• 4 Errors in assays, machines, labelling• 5 Made up, fraudulent
![Page 23: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/23.jpg)
Type 1 error (Plausibility)• RCT• Placebo controlled• Predefined primary endpoint; pre-
eclampsia• Predefined analysis• Significant difference: RRR 0.8 (CI 0.71 –
0.89), p <0.001• Population:Odd numbers vs even numbers
![Page 24: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/24.jpg)
Type 1 error (predefined endpoint)
05
10152025
Number of women with
pre-eclampsia
Intention-to-treat
Completedstudy
PlaceboVitamins C and E
![Page 25: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/25.jpg)
Effect of vitamins on PAI-1/PAI-2 ratio
Gestation (weeks)
20 24 28 32 36
PAI-1
/PAI
-2 ra
tio
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50Control Placebo Vitamin
Chappell et al 2002
Predefined primary endpoint
![Page 26: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/26.jpg)
Why is p < 0.05?Alpha, or chance of False Positive? Because we have 5 fingers
![Page 27: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/27.jpg)
Fetal Monitoring: Type 2 errors?
![Page 28: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/28.jpg)
Randomised trials
• INFANT
– Intelligent decision support in the interpretation of the intrapartum CTG in labour - 46,000 women
– Eligibility – women who are judged to require continuous electronic fetal monitoring in labour
– Outcome – NE, IP stillbirth
![Page 29: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/29.jpg)
INFANT
![Page 30: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/30.jpg)
Infant: Primary outcome
• “Poor neonatal outcome”:• Deaths (excluding congenital anomalies):
– Intrapartum stillbirth
– Neonatal
• Neonatal encephalopathy:– Severe/moderate– Mild
• Other significant morbidity:– Other admissions to NICU within 48 hrs of birth for ≥ 48
hrs e.g. respiratory symptoms, seizures
• Developmental quotient at age 2 years
![Page 31: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/31.jpg)
INFANT Sample size
Assuming: Poor neonatal outcome rate:3 per1000 births• 5% significance level • 90% power
– 50% reduction in poor neonatal outcome rate e.g. to compare 3 versus 1.5 per 1000
Need: 46,000 births in total (22,279 per arm)
![Page 32: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/32.jpg)
RCT (event rate also important) Seat belt vs No seat belt
20,000,000Car
Journeys/day
10,000,000Seat Belt
10,000,000No Seat Belt
![Page 33: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/33.jpg)
RCT: Seat belt vs No seat belt
20,000,000Car
Journeys/day
Seat Belt2 deaths
No Seat Belt8 deaths
![Page 34: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/34.jpg)
Conclusions?
• Seat belts do not save lives, and should be abandoned as they limit the comfort and mobility of the passenger.
![Page 35: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/35.jpg)
Conclusion
• This study is underpowered to determine the effect of seat belts on saving lives.
![Page 36: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/36.jpg)
Type 3 error
Proportion of mothers giving birth, by gestational ageand randomised treatment: A[___] or B[---]
Pro
porti
on d
eliv
ered
Gestational age at birth (weeks)0 10 20 30 4024 37
0.00
0.25
0.50
0.75
1.00
A
B
![Page 37: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/37.jpg)
0
10
20
30
40
50
60
70
Placebo Roficoxib
![Page 38: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/38.jpg)
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET
Study
BJOG. 2006 Jan;113(1):65-74Andrew Shennan, Sarah Crawshaw, Annette Briley,
Jenny Hawken, Paul Seed, Griff Jones, Lucilla Poston
0%
10%
20%
30%
40%
50%
60%
70%
Metronidazole Placebo
PTB
N=900 screened / 100 randomised
![Page 39: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/39.jpg)
Risk Ratio
.1 1 10
Combined
Premet, 2004
Odendaal H et al., 2002
Klebanoff M et al., 2001
Carey J et al., 2000
McDonald H et al., 1997
Morales W et al., 1994
Studies involving metronidazole without erythromycin only
![Page 40: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/40.jpg)
Type 4 error
0
10
20
30
40
50
60
70
Trad CSE LDI
COMET trial
![Page 41: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/41.jpg)
Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a
randomised controlled trialThe Lancet, Volume 358, Issue 9275,
Pages 19 - 23, 7 July 2001The COMET study Group Shennan et al.
05
1015202530354045
Trad CSE LDI
% SVD
N=1054 (x2)
P=0.04
![Page 42: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/42.jpg)
Cochrane: feeding is safe?Type 0?? Right answer, wrong question
A Randomised Controlled Trial to Evaluate the Effect of Food intake during Labour
on Obstetric Outcome
0%5%
10%15%20%25%30%35%40%45%
Food Water
SVD N=2500
![Page 43: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/43.jpg)
Num
ber o
f dea
ths
Middle year of triennium
Maternal deaths due to anaesthesia(1952-2008)
![Page 44: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/44.jpg)
Beware the hidden agenda!Restricting oral intake in labour
“No benefit or harm, therefore do not restrict……”
![Page 45: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/45.jpg)
?
• No studies looked specifically at women at increased risk of complications, hence there is no evidence to support restrictions in this group of women.
![Page 46: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/46.jpg)
Should women drink/eat during labor ?
We will never have the clinical trial evidence to ensure safety but in recent years we have seen….
• No increase in pulmonary aspiration– (4 deaths in 10,000,000 deliveries in UK)
In spite of….• Considerable Increase in feeding practice• Increase in C/S and therefore now GAs
![Page 47: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/47.jpg)
Type 5 error…..Malcolm Pearce
• Obstetrician suspended after research inquiry.
• Faked a report about transplantation of an ectopic pregnancy.
![Page 48: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/48.jpg)
Upright versus recumbent position in the second stage of labour in women with combined spinal-epidural
analgesiaM. Golara, MRCOG, F. Plaat, FRCA, A.H. Shennan, MD
MRCOGInt J Obstet Anesth. 2002 Jan;11(1):19-22
0
20
40
60
80
100
120
140
Upright Recumbant
Length labour(minutes)
N=66
![Page 49: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/49.jpg)
NIHR Health Technology Assessment ProgramISRCTN 35706297
![Page 50: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/50.jpg)
Research model
Multicentre RCT41 UnitsN=30501 year pilot phase2 years recruitment
£3.2M
![Page 51: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/51.jpg)
Singleton, cephalic, term, nulliparaeMobile epidural
Upright Lying Down
Enter 2nd Stage
Power: 0.9 To detect a RR SVD
0.6
N=3237Reporting 2015
![Page 52: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/52.jpg)
Funding bodies
WellcomeMRCNIHR HTA RfPB Fellowships
National Charities“The harder it is, the less likely someone
else is going to do it.”
![Page 53: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/53.jpg)
Conclusion• Research informs everything we do• Research active clinicians have better outcomes• We have an obligation to offer research to our
patients, and many want it• Publishing your experience disseminates your
knowledge to many and forever• Research is personally rewarding• UK provides a globally unique opportunity to
engage with health research• Academics live longer
![Page 54: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/54.jpg)
Geraldine O’Sullivan
Befriend an Obstetric AnaethetistBefriend a clinical academic
![Page 55: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH](https://reader036.vdocuments.us/reader036/viewer/2022070823/5f2ebbced344df3b79467a3b/html5/thumbnails/55.jpg)
The Future….
Anaesthesia and perioperative care priority setting partnership